[go: up one dir, main page]

NZ604009A - A combination composition comprising ibuprofen and paracetamol - Google Patents

A combination composition comprising ibuprofen and paracetamol

Info

Publication number
NZ604009A
NZ604009A NZ60400911A NZ60400911A NZ604009A NZ 604009 A NZ604009 A NZ 604009A NZ 60400911 A NZ60400911 A NZ 60400911A NZ 60400911 A NZ60400911 A NZ 60400911A NZ 604009 A NZ604009 A NZ 604009A
Authority
NZ
New Zealand
Prior art keywords
paracetamol
ibuprofen
approximately
combination composition
combination
Prior art date
Application number
NZ60400911A
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Priority to NZ60400911A priority Critical patent/NZ604009A/en
Publication of NZ604009A publication Critical patent/NZ604009A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed herein is the use of ibuprofen and paracetamol in the manufacture of a combination medicament for treating pain and/or inflammation in a human by intravenous administration, the medicament having: a) approximately 375 mg to approximately 425 mg ibuprofen, in combination with approximately 975 mg to approximately 1,025 mg paracetamol; or b) approximately 175 mg to approximately 225 mg ibuprofen, in combination with 475 mg to 525 mg paracetamol.
NZ60400911A 2010-07-07 2011-06-21 A combination composition comprising ibuprofen and paracetamol NZ604009A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ60400911A NZ604009A (en) 2010-07-07 2011-06-21 A combination composition comprising ibuprofen and paracetamol

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ58666110 2010-07-07
PCT/NZ2011/000117 WO2012005605A1 (en) 2010-07-07 2011-06-21 A combination composition comprising ibuprofen and paracetamol
NZ60400911A NZ604009A (en) 2010-07-07 2011-06-21 A combination composition comprising ibuprofen and paracetamol

Publications (1)

Publication Number Publication Date
NZ604009A true NZ604009A (en) 2015-03-27

Family

ID=45441395

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ60400911A NZ604009A (en) 2010-07-07 2011-06-21 A combination composition comprising ibuprofen and paracetamol

Country Status (6)

Country Link
AU (1) AU2011274652B2 (en)
MY (1) MY164112A (en)
NZ (1) NZ604009A (en)
SG (1) SG186388A1 (en)
WO (1) WO2012005605A1 (en)
ZA (1) ZA201208210B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2814057C (en) * 2010-11-04 2022-02-01 Aft Pharmaceuticals Limited Intravenous composition comprising paracetamol and ibuprofen
CN103565733A (en) * 2012-07-31 2014-02-12 南京帝易医药科技有限公司 Ibuprofen sodium chloride injection preparation with pH of 6.0-6.5, and preparation method thereof
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101370712B1 (en) * 2004-07-07 2014-03-06 에이에프티 파마슈티칼스 리미티드 A combination composition
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
AU2011274652A1 (en) 2013-01-10
WO2012005605A1 (en) 2012-01-12
AU2011274652B2 (en) 2013-08-15
SG186388A1 (en) 2013-01-30
MY164112A (en) 2017-11-30
ZA201208210B (en) 2014-04-30

Similar Documents

Publication Publication Date Title
PH12021550804A1 (en) A combination composition
IL201479A (en) Use of tapentadol for the manufacture of a medicament for the treatment of pain
EA201290833A1 (en) APPLICATION OF AMISULPRIDE AS ANTI-TRAFFIC MEANS
MY173215A (en) Acetylcysteine compositions and methods of use thereof
NZ707377A (en) Combination therapy methods for treating proliferative diseases
MX2011007589A (en) Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody.
NZ612717A (en) Treatment of pain associated with dislocation of basal endometrium
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
HK1221646A1 (en) Use of high dose pridopidine for treating huntington's disease
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
MX358491B (en) A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate.
NZ595046A (en) Compositions and methods for extended therapy with aminopyridines
JP2013541583A5 (en)
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
NZ591496A (en) A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
MY174442A (en) Treating critically ill patients with intravenous ibuprofen
NZ597675A (en) Medicament for the long term nsaid use
MX2011012668A (en) Methods of administration of thrombopoietin agonist compounds.
UA61955U (en) method for treating patients with erythematous-bullous erysipelas
RU2012158011A (en) METHOD AND COMPOSITION FOR TREATMENT OF CANCER
RU2010124455A (en) METHOD FOR TREATING SUFFERED WITH COMBINED CRANIO-BRAIN INJURY

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 21 JUN 2018 BY A J PIETRAS + CO

Effective date: 20150630

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2019 BY CPA GLOBAL

Effective date: 20180517

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2020 BY CPA GLOBAL

Effective date: 20190516

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2021 BY CPA GLOBAL

Effective date: 20200521

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2022 BY CPA GLOBAL

Effective date: 20210520

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2023 BY CPA GLOBAL

Effective date: 20220519

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2024 BY CPA GLOBAL

Effective date: 20230518

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20240517

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20250522